Dr. Bhupalam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2160 S 1st Ave
Maywood, IL 60153Phone+1 708-216-9000Fax+1 502-238-2835
Summary
- Leela Bhupalam, MD is an oncologist based in Louisville, KY, with a focus on breast cancer and hematologic oncology. She completed her fellowship in Hematology and Medical Oncology as well as residencies in Internal Medicine and Psychiatry at the University of Louisville School of Medicine. Dr. Bhupalam has contributed to numerous publications, most notably in The International Journal of Neuroscience and The American Journal of Medical Science. She has conducted multiple clinical trials, including those involving aggressive B-cell Non-Hodgkin Lymphoma and Stage IV Breast Cancer. In 2013, she received the CMS Meaningful Use Stage 1 Certification from MOSAIQ EMR, Elekta.
Education & Training
University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 1994 - 1996- University of Louisville School of MedicineResidency, Internal Medicine, 1991 - 1993
- University of Louisville School of MedicineResidency, Psychiatry, 1989 - 1991
M. Rampure Medical CollegeClass of 1983
Certifications & Licensure
IL State Medical License 2024 - 2026
KY State Medical License 1992 - 2025
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
Clinical Trials
- Assessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone Metastasis Start of enrollment: 2004 Sep 01
- Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant Start of enrollment: 2011 Apr 20
Publications & Presentations
PubMed
- 1 citationsAnaplastic oligodendroglioma metastasizing to the bone marrow: a unique case report and literature review.Vikas Singh, Shipra Singh, Leela Bhupalam
The International Journal of Neuroscience. 2019-02-13 - 3 citationsFixed-Dose Every-Other-Week Capecitabine and Oxaliplatin for Refractory Squamous Cell Carcinoma of the Head and NeckGuilherme Rabinowits, Leela Bhupalam, Donald M. Miller, Goetz H. Kloecker, Damian A. Laber
The American Journal of the Medical Sciences. 2010-02-01 - 4 citationsAdvances in the management of metastatic androgen-independent prostate cancer.Damian A. Laber, Goetz H K, Leela Bhupalam
The Journal of the Kentucky Medical Association. 2006-02-01
Committees
- Member, Breast cancer committee 2012 - 2015
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
